1
TITLE: Are smart delivery systems the solution to overcome the lack of selectivity of current metallodrugs in cancer therapy?  Full Text
AUTHORS: Machado, JF ; Morais, TS;
PUBLISHED: 2022, SOURCE: DALTON TRANSACTIONS, VOLUME: 51, ISSUE: 7
INDEXED IN: Scopus WOS CrossRef: 2
IN MY: ORCID
3
TITLE: Gold(I) Bis(1,2,3-triazol-5-ylidene) Complexes as Promising Selective Anticancer Compounds  Full Text
AUTHORS: Schlagintweit, JF; Jakob, CHG; Wilke, NL; Ahrweiler, M; Frias, C; Frias, J; Konig, M; Esslinger, EMHJ; Marques, F; Machado, JF ; Reich, RM; Morais, TS; Correia, JDG; Prokop, A; Kuhn, FE;
PUBLISHED: 2021, SOURCE: JOURNAL OF MEDICINAL CHEMISTRY, VOLUME: 64, ISSUE: 21
INDEXED IN: Scopus WOS CrossRef: 7
IN MY: ORCID
5
TITLE: New copper(i) complexes selective for prostate cancer cells  Full Text
AUTHORS: Machado, JF ; Sequeira, D; Marques, F; Piedade, MFM; de Brito, MVJ; Garcia, MH; Fernandes, AR; Morais, TS;
PUBLISHED: 2020, SOURCE: DALTON TRANSACTIONS, VOLUME: 49, ISSUE: 35
INDEXED IN: WOS CrossRef: 4
IN MY: ORCID
7
TITLE: Thiol-to-amine cyclization reaction enables screening of large libraries of macrocyclic compounds and the generation of sub-kilodalton ligands
AUTHORS: Kale, SS; Bergeron-Brlek, M; Wu, Y; Kumar, MG; Pham, MV; Bortoli, J; Vesin, J; X.-D Kong; Franco F Machado ; Deyle, K; Gonschorek, P; Turcatti, G; Cendron, L; Angelini, A; Heinis, C;
PUBLISHED: 2019, SOURCE: Science Advances, VOLUME: 5, ISSUE: 8
INDEXED IN: CrossRef: 24
IN MY: ORCID
8
TITLE: Less Exploited GPCRs in Precision Medicine: Targets for Molecular Imaging and Theranostics  Full Text
AUTHORS: Franco Machado, J ; Silva, RD; Melo, R; G Correia, JD;
PUBLISHED: 2018, SOURCE: Molecules (Basel, Switzerland), VOLUME: 24, ISSUE: 1
INDEXED IN: Scopus CrossRef: 9
IN MY: ORCID